Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kyowa Kirin sells China plant to Dainippon Sumitomo

This article was originally published in Scrip

Executive Summary

Kyowa Hakko Kirin is to divest a wholly owned Chinese pharmaceutical manufacturing subsidiary to Dainippon Sumitomo Pharma(DSP). The former Kyowa Hakko packaging plant in Suzhou was completed in 2006 but had not begun commercial operations, and is being sold as part of restructuring following Kyowa's October 1st merger with Kirin. Financial terms were not disclosed but the subsidiary has net assets of around ¥1.5 billion ($15.5 million). DSP said it was looking to expand its local production capacity to meet growing demand in China, where it already has a marketing subsidiary and a packaging facility, also in Suzhou.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts